Little Green Pharma Ltd. (AU:LGP) has released an update.
Little Green Pharma Ltd. reported a record revenue of $10.2 million for the quarter ended September 2024, marking a 40% increase from the previous quarter, driven by strong growth in the European cannabis markets. The company also achieved a net operating cash inflow, resulting in a cashflow positive quarter, and improved its cash position to $4.8 million. Cost savings from subcontracting Australian operations are expected to further enhance their financial performance.
For further insights into AU:LGP stock, check out TipRanks’ Stock Analysis page.